SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-27
DOI
10.1038/s41388-023-02840-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The KMT2A recombinome of acute leukemias in 2023
- (2023) C. Meyer et al. LEUKEMIA
- High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML
- (2023) Yoana Arroyo-Berdugo et al. Cancers
- RAS and PP2A activities converge on epigenetic gene regulation
- (2023) Anna Aakula et al. Life Science Alliance
- Identification of a c-MYB-directed therapeutic for acute myeloid leukemia
- (2022) Katherine Clesham et al. LEUKEMIA
- Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
- (2022) Dongxu Li et al. ONCOGENE
- Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias
- (2022) Sandra Cantilena et al. Clinical and Translational Medicine
- Thirty years of SET/TAF1β/I2PP2A: from the identification of the biological functions to its implications in cancer and Alzheimer’s disease
- (2022) Antonella Di Mambro et al. BIOSCIENCE REPORTS
- The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
- (2021) Stephin J. Vervoort et al. CELL
- Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates HOXA9 Gene Expression in t(4;11) Leukemia Cells
- (2021) Tiziana Fioretti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SET‐NUP214 and MLL cooperatively regulate the promoter activity of the HoxA10 gene
- (2021) Sadik Cigdem et al. GENES TO CELLS
- HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways
- (2021) Ryo Miyamoto et al. eLife
- Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
- (2021) Alexia Tsakaneli et al. Frontiers in Pharmacology
- The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis
- (2021) Mahshid Ghasemi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis
- (2020) Jue Jiang et al. CANCER CELL
- Phosphoproteome and drug response effects mediated by the three Protein Phosphatase 2A inhibitor proteins CIP2A, SET and PME-1
- (2020) Otto Kauko et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring
- (2020) Maruan Hijazi et al. NATURE BIOTECHNOLOGY
- A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia
- (2020) Elena Arriazu et al. Blood Cancer Journal
- Novel therapeutic strategies for MLL-rearranged leukemias
- (2020) Nok-Hei Mickey Wong et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction
- (2019) Ryan M. De Palma et al. FASEB JOURNAL
- Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
- (2019) Anthony K. N. Chan et al. Frontiers in Cell and Developmental Biology
- Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation
- (2019) Tiziana Fioretti et al. CELLULAR ONCOLOGY
- FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia
- (2019) Megan M. Young et al. Cell Death & Disease
- A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
- (2019) Carmen Vicente et al. CANCER LETTERS
- HBO1 is required for the maintenance of leukaemia stem cells
- (2019) Laura MacPherson et al. NATURE
- SET Oncogene is Upregulated in Pediatric Acute Lymphoblastic Leukemia
- (2018) Sema Sirma Ekmekci et al. TUMORI
- PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas
- (2018) Yuan Ren et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting acute myeloid leukemia by drug-induced c-MYB degradation
- (2017) V Walf-Vorderwülbecke et al. LEUKEMIA
- MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
- (2017) Amanda C. Winters et al. Frontiers in Pediatrics
- Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
- (2016) M N Cruickshank et al. LEUKEMIA
- Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation
- (2016) A N McCracken et al. LEUKEMIA
- Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival
- (2016) Daibiao Xiao et al. MOLECULAR CELL
- MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia
- (2016) Raffaella Pippa et al. Oncotarget
- The emerging role of FTY720 (Fingolimod) in cancer treatment
- (2016) Christopher White et al. Oncotarget
- Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A
- (2015) F. Zonta et al. BLOOD
- The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
- (2015) A. Baker et al. CANCER RESEARCH
- The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
- (2015) Vincent-Philippe Lavallée et al. NATURE GENETICS
- Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
- (2015) Maria Teresa Esposito et al. NATURE MEDICINE
- PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects
- (2015) Raúl Rincón et al. Oncotarget
- From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies
- (2015) Maria Ciccone et al. Frontiers in Oncology
- Effect of FTY720 on the SET–PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity
- (2014) R Pippa et al. LEUKEMIA
- Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models
- (2014) Lays M Sobral et al. Molecular Cancer
- Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer
- (2014) Amy S. Farrell et al. MOLECULAR CANCER RESEARCH
- PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential
- (2014) I. Cristobal et al. MOLECULAR CANCER THERAPEUTICS
- FTY720 Induces Apoptosis of M2 Subtype Acute Myeloid Leukemia Cells by Targeting Sphingolipid Metabolism and Increasing Endogenous Ceramide Levels
- (2014) Limin Chen et al. PLoS One
- Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer
- (2014) M. Janghorban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic fusion proteins expressed in immature hematopoietic cells fail to recapitulate the transcriptional changes observed in human AML
- (2014) N Rapin et al. Oncogenesis
- PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
- (2013) Paolo Neviani et al. JOURNAL OF CLINICAL INVESTIGATION
- Protein phosphatase 2A: a target for anticancer therapy
- (2013) Danilo Perrotti et al. LANCET ONCOLOGY
- Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML
- (2013) K R Kampen et al. LEUKEMIA
- Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease
- (2013) Guang Yu et al. NEUROBIOLOGY OF AGING
- Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells
- (2013) P. Casado et al. Science Signaling
- FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells
- (2011) Craig T. Wallington-Beddoe et al. Autophagy
- SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target
- (2011) D. J. Christensen et al. BLOOD
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia
- (2011) I. Cristobal et al. HAEMATOLOGICA
- PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
- (2011) I Cristóbal et al. LEUKEMIA
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
- (2011) C H Switzer et al. ONCOGENE
- Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers
- (2010) K. G. Roberts et al. CANCER RESEARCH
- Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
- (2010) Andrew J. Gentles JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem Cells
- (2009) Tim C.P. Somervaille et al. Cell Stem Cell
- HOXA9 is required for survival in human MLL-rearranged acute leukemias
- (2008) J. Faber et al. BLOOD
- An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
- (2008) K. H. Metzeler et al. BLOOD
- The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia
- (2008) P. Van Vlierberghe et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now